New antibody pair could defeat all SARS-CoV-2 variants

FHS
March 6, 2025
5:03 am

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep pace with evolving viruses.

How a Trump presidency could affect the FDA, the biotech industry, and its stocks

Is less regulation by the Food and Drug Administration good for the biotech industry? Do vaccine makers like Pfizer have a target on their back

November 7, 2024

Vertex says another type 1 diabetes patient is insulin-free in updated data out of EASD

Vertex Pharmaceuticals’ islet cell therapy has produced more promising early data in type 1 diabetes patients, with a third reaching independence from insulin and all

October 4, 2023

How Community Schools Can Improve Their Healthcare Initiatives

Thomas Shaffer, President, Campus Clinic If you ever visited the nurses’ office or had an eye exam at school as a child, you benefitted from

December 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.